Data are lacking regarding the impact of visible pigment on rectal swab diagnostic accuracy. We describe the test characteristics of rectal swabs with and without pigment in children with gastroenteritis. Between December 2014 and September 2017, children (age, Ͻ18 years) with Ն3 episodes of vomiting and/or diarrhea in a 24-h period and symptoms for Ͻ7 days were enrolled through two pediatric emergency departments and from a province-wide nursing telephone advice line in Alberta, Canada. Specimens were analyzed by employing nucleic acid amplification panels. The primary outcomes were the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the rectal swabs, with stool specimen results being used as the reference standard. An enteropathogen was detected in 76.0% (1,399/1,841) of the paired specimens. A total of 54.4% (1,001/1841) of the swabs had visible pigment. The respective enteropathogen detection characteristics of swabs with and without visible pigment were as follows: 92.2% (95% confidence interval [CI], 90.0%, 94.0%) versus 83.7% (95% CI, 80.5%, 86.4%) for sensitivity, 94.3% (95% CI, 90.5%, 96.6%) versus 91.2% (95% CI, 86.3%, 94.5%) for specificity, 97.9% (95% CI, 96.4%, 98.8%) versus 96.5% (95% CI, 94.5%, 97.8%) for PPV, and 80.9% (95% CI, 76.0%, 85.1%) versus 65.8% (95% CI, 60.0%, 71.1%) for NPV. Processing of swabs without visible pigment would increase the rate of identification of positive swabs from 50.0% (682/1,365) to 88.3% (1,205/1,365). There is a modest decrease in the reliability of a negative test on swabs without evidence of pigment, but the overall yield is significantly greater when they are not excluded from testing. Hence, rectal swabs without visible feces should not be routinely rejected from testing.
O btaining stool from children is challenging, particularly in outpatient settings, as a sample is frequently not provided by the child during medical visits (1) , thereby prolonging the time to results because of delays in specimen acquisition (2) . Handling of bulk stools also increases exposure risk. Flocked rectal swabs are a potential alternative that compares favorably with stool specimens (3) (4) (5) (6) , including when they are obtained from patients with isolated vomiting (3) . Professional society guidelines endorse rectal swab use in children if timely stool specimens cannot be obtained (7) , but only when visible pigment is noted on the swab (8) .
Evidence to support the requirement of visible pigment is sparse. In one study, approximately 10% of rectal swab specimens received in the microbiology laboratory were excluded from processing due to the absence of visible pigment (9) , and an unknown proportion were not even submitted from the point of collection for similar reasons. The absence of visible pigment on a swab is presumed to indicate that the stool sample on the swab is inadequate, but no published data support the superior sensitivity of swabs with visible feces. As such, we sought to determine if visible pigment on a swab affects the diagnostic performance of a multiplex nucleic acid test for acute gastroenteritis using rectal swabs.
MATERIALS AND METHODS
Study design. This report is a secondary analysis of data collected as part of the Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE) study (10) . From 1 December 2014 to 30 September 2017, eligible children were consecutively enrolled in pediatric emergency departments (EDs) at the Alberta Children's Hospital (Calgary, AB, Canada) and the Stollery Children's Hospital (Edmonton, AB, Canada). Eligible children were Ͻ18 years of age, had had at least three episodes of vomiting and/or diarrhea in the preceding 24 h, had had Ͻ7 days of symptoms, and submitted paired rectal swab and stool specimens. Bulk stool specimen results were considered the reference standard. We excluded children who had been enrolled in this study within the previous 14 days and those presenting with psychiatric concerns or neutropenia or requiring emergent medical intervention. In a second cohort, children (home participants) meeting eligibility criteria who had contacted Health Link (Alberta Health Services), a province-wide nursing triage telephone advice line, were enrolled if the recommendation provided was to continue care at home.
Informed consent was provided by caregivers; assent was obtained when participants were deemed sufficiently mature to understand study procedures and the potential benefits and harms. The research ethics boards of the University of Calgary and University of Alberta approved this study.
Specimen acquisition and processing. A standardized data collection form was used to collect demographic and clinical information. Each participant provided a dry rectal swab (FLOQSwab; Copan Italia, Brescia, Italy) and a fecal specimen for testing. In the ED, swab specimens were obtained by a study nurse, who inserted the swab into the rectum and then rotated the swab 360°. For children enrolled through Health Link, swab and fecal specimens were collected by their caregivers using kits that were couriered to their home.
The dry rectal swab was transported in a sterile tube (Copan Italia, Brescia, Italy); fecal specimens were collected in sterile containers (catalog number V302-F; Starplex Scientific, ON, Canada). If a fecal specimen was not provided before ED discharge, caregivers were asked to collect the sample at home. Specimens were stored at room temperature for up to 12 h while awaiting retrieval by a study-funded courier, who transported the specimens to the laboratory on ice packs.
Upon specimen receipt and before processing, laboratory personnel visually inspected the swabs and scored them as having either visible fecal material or pigment (i.e., discoloration of the swab) or no indications of fecal content. After initial processing, stool samples and dry rectal swabs were stored at Ϫ80°C until nucleic acid amplification testing was performed.
Molecular testing. Nucleic acid extracted from the rectal swabs was tested with a Luminex xTAG gastrointestinal pathogen panel (GPP; Luminex Molecular Diagnostics, ON, Canada) (6, 11) . In addition, all specimens were tested using an in-house real-time PCR gastroenteritis virus panel (GVP) that detects adenovirus, astrovirus, norovirus, rotavirus, and sapovirus (12) .
Nucleic acid was extracted using a NucliSENS easyMag extractor (bioMérieux, Marcy l'Etoile, France). Dry fecal swabs were immersed in 750 l of NucliSENS easyMAG lysis buffer and mixed. Three hundred microliters of the suspension was added to Bertin SK38 soil grinding lysis bead tubes (Luminex Molecular Diagnostics) along with 10 l of bacteriophage MS2 (Luminex Molecular Diagnostics) to a final volume of 1,000 l. For stool specimens, nucleic acid was extracted from 100 to 150 mg of solid stool or 100 l of liquid stool. Nucleic acid extracted from the two sample types was eluted to a final volume of 70 l and stored at Ϫ80°C until further testing using the GPP and the GVP (12) .
A 10-l nucleic acid extract was used in the GPP assay. For the GVP assay, 5 l of nucleic acid extract was used to generate cDNA by reverse transcription reactions with a final volume of 20 l (12). Each duplex real-time PCR assay targeting norovirus genogroup I (GI) and GII, rotavirus and adenovirus, or sapovirus and astrovirus contained 3.5 l of cDNA in a final volume of 10 l. The reaction was performed using a 7500 Fast real-time PCR system (Applied Biosystems, Foster City, CA, USA). Cycle threshold (C T ) values of 38 or lower were considered positive.
Outcomes. The primary outcomes were the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the rectal swabs with and without visible pigment for enteropathogen detection on either molecular testing platform, with stool specimen test results being used as the reference standard. Secondary outcomes included the sensitivity, specificity, PPV, and NPV for rectal swabs with and without visible pigment based on the testing platform (i.e., GVP and GPP) and pathogen targets (with combined results from GVP and GPP for viral detection). Other secondary outcomes included overall enteropathogen positivity and the C T values from the GVP platform for rectal swabs with and without visible pigment.
Statistical analysis. For the primary outcomes, we derived 95% confidence intervals (CI) using Wilson's procedure with a continuity correction (13, 14) . We conducted subgroup analyses of the primary outcomes for (i) the presence of diarrhea or isolated vomiting at the time of specimen collection and (ii) the specimen collection group (i.e., ED versus home). Isolated vomiting was defined as vomiting without diarrhea. To evaluate if the interval between specimen collection (i.e., collection of the rectal swab earlier than collection of stool) affects specimen test characteristics, calculations were repeated with the analysis restricted to specimens collected within 24 h of each other. Because Clostridioides difficile is identified in many asymptomatic young children (15, 16) , analyses were also repeated without consideration of C. difficile detection in children Ͻ2 years of age.
Test characteristics for the secondary outcomes were analyzed as described above for the primary outcomes (see Table S1 in the supplemental material). A multivariable logistic regression assessed the association between enteropathogen positivity (the dependent variable) and the presence of visible pigment (the independent variable). The model was adjusted for a priori potential confounders, including the presence of diarrhea and the collection group (i.e., ED versus home). Model coefficients were exponentiated to provide estimates of the odds ratio (OR). We compared the cycle threshold values of positive GVP tests with versus without visible pigment using the Mann-Whitney U test. Two-tailed P values of Ͻ0.05 were considered statistically significant. Analyses were conducted using SPSS (version 24.0) software (IBM Corp., Armonk, NY).
RESULTS
Of the 2,847 participants enrolled, 2,530 (88.8%) and 1,941 (67.2%) contributed rectal swabs and stool specimens, respectively. The 1,841 (64.7%) participants with paired specimens and documentation of the presence or absence of visible pigment were included in the analysis (Fig. 1 ). The participant median age was 17.8 months (interquartile range [IQR], 10.1, 36.2 months), and the median illness duration at enrollment was 46 h (IQR, 18, 89 h) ( Table 1 ). The median time interval between illness onset and specimen acquisition was 60.3 h (IQR, 22.0, 102.5 h) for rectal swabs and 80.4 h (IQR, 42.0, 123.0 h) for stool specimens.
Visible pigment was present on the rectal swab for 54.4% (1,001/1,841) of the rectal swabs with paired specimens. Rectal swabs collected at home more often had visible pigment than those submitted in the ED (home, 68.4% [270/395]; ED, 50.6% [731/1,446]; P Ͻ 0.001). There was a shorter interval between collection of rectal swabs with visible pigment and collection of the corresponding stool specimen than between collection of rectal swabs without visible pigment and collection of the corresponding stool specimen (0.5 h [IQR, 0, 17.5 h] versus 7.5 h [IQR, 0.3, 24.8 h]; P Ͻ0.001).
At least one enteropathogen was detected in 76.0% (1,399/1,841) of the paired specimens. In 160 (11.4%) pairings, only the stool specimen was positive, while in 34 (2.4%), only the rectal swab was positive (see Table S2 (Table 3) .
Of the 1,365 participants whose stool specimen contained an enteropathogen, 682 (50.0%) of the corresponding rectal swab specimens had both visible pigment and a detected pathogen. Inclusion of rectal swabs without visible pigment but with a pathogen detected (n ϭ 523) increased the proportion of participants with a positive stool specimen identified by use of a rectal swab to 88.3% (n ϭ 1,205) ( Table 2 ). Of the 34 participants whose rectal swab specimens were positive while the related bulk stool tested negative, 19 (56%) of the swabs had no visible pigment.
Secondary outcomes. Differences in sensitivity, specificity, PPV, and NPV between swabs with and without visible pigment were consistent on both molecular diagnostic platforms (Table 4) .
Pathogen group analysis demonstrated that swabs with visible pigment had a greater sensitivity and NPV than swabs without visible pigment and specificity and PPV similar to those for swabs without visible pigment for the identification of viral pathogens ( Table 4 ). The finding did not change significantly when C. difficile detection in children Ͻ2 years of age was considered negative.
Regression analysis (n ϭ 2,458) of overall pathogen positivity demonstrated no difference in enteropathogen detection associated with visible pigment after adjustment for diarrhea presence and sampling group (OR ϭ 0.85; 95% CI, 0.71, 1.01; P ϭ 0.07) Table S3 in the supplemental material). (Table S6 and Fig. 2 ).
DISCUSSION
Although swabs without visible pigment had a lower sensitivity and NPV than rectal swabs with visible pigment, when stool was employed as the reference standard, no significant difference in specificity or PPV was observed. Although swab specimens often lack visible pigment, processing them when stool is not available increased the absolute detection rate of pathogens from 50% to 88%. Although the presence of pigment is preferred, there are significant losses in diagnostic yield if swabs without pigment are rejected from testing. We suggest that laboratories consider processing flocked rectal swabs irrespective of feces visibility. Reports should note when pigment is not observed on the swab and that this may decrease the diagnostic sensitivity of the test and should prompt recollection of a specimen if it is clinically indicated.
Our findings call into question the Infectious Diseases Society of America recommendation that rectal swabs without visible feces not be tested by diagnostic microbiology laboratories (8), as we found that sensitivity was reduced by only 8.5% and the NPV was reduced by only by 15.2% in the absence of pigment. Moreover, the reduction in sensitivity was even less when children presented with diarrhea. While reduced diagnostic test characteristics are disadvantages, the overall diagnostic performance of rectal swabs without visible feces (sensitivity, 83.7% to 92.2%; specificity, 91.2% to 94.3%) is still clinically acceptable and considerably better than not testing a swab specimen at all. Rejecting swabs without visible pigment would mean that nearly 50% of rectal swabs would be discarded. While the advantages of testing a swab without visible pigment include (i) the provision of crucial and timely diagnostic information to Table S1 in the supplemental material). c C. difficile-positive results for children Ͻ2.0 years of age coded as negative. guide therapy and public health strategy and (ii) child and care provider avoidance of the nuisance and potential risk of specimen collection at home, these benefits need to be considered in the context of the potential need to retest, which carries with it financial implications. Accepting swabs without pigment may lower the overall quality of rectal swab submissions, but we consider this unlikely for several reasons. First, the swabs analyzed for this study were collected for research purposes by nonresearch personnel (i.e., bedside nurses and caregivers); thus, there was little extrinsic motivation to ensure that there was pigment on the swab. Second, the procedure is simple and standardized. The swabs have a flange indicating the desired depth of insertion; there is little that one can do to get a better specimen. Lastly, caregiver collection at home (i.e., by untrained individuals) is as good as or better than collection by medical professionals at yielding a pathogen (3).
The lower sensitivity of rectal swabs when pigment is not visible likely reflects the reduced amount of fecal material extracted for testing and, thus, a lower pathogen load following nucleic acid extraction (12, 17) . This hypothesis is supported by the higher C T values among positive rectal swabs without visible fecal material and our finding that the magnitude of the reduced detection sensitivity was greater among children with isolated vomiting. Our findings were stable across the two collection groups and the two testing platforms, suggesting that results are related to the quality of the specimen. The possibility exists that the diagnostic yield of swabs without visible feces could be increased by modifying nucleic acid extraction steps and innovations in detection technologies, as has been accomplished on buccal swabs obtained for forensic purposes (18) .
A possible explanation for the overall greater reduction in the sensitivity among rectal swabs without visible pigment to detect bacteria than to detect viruses was the high rate of detection of C. difficile, which was detected in 2.8% more swabs with pigment visible than in those without visible pigment. As young children are often colonized with C. difficile (15, 19) with low pathogen loads, the C. difficile density might more often be below the detection limit in swabs without visible feces. This hypothesis is supported by evidence that among toxin-positive C. difficile-infected patients, toxin concentrations are significantly higher and C T values are significantly lower than those among carriers (20) and by our findings of the significantly reduced sensitivity of rectal swabs without pigment to detect C. difficile.
We acknowledge a number of study limitations. First, we did not assess the impact of rectal swabs without visible pigment on the sensitivity of bacterial culture. However, C T values have been demonstrated to relate to culture yield, so the results are likely transferable (21) . Second, even though we assessed two molecular testing panels, alternative commercially available systems may have different sensitivity thresholds. Nonetheless, the similarity of our findings between the two panels studied suggests that our results might be generalizable to other test methods. Additionally, there were few bacterial and parasitic pathogens identified in this cohort, so more evidence regarding the use of rectal swabs without visible pigment for the detection of such pathogens and in cohorts with different pathogen distributions is needed (22) . Also, a significant number of participants did not submit stool specimens and, thus, were excluded from the primary analysis; however, regression analysis included all tested rectal swab specimens, and it did not find a significant difference between the rectal swab groups.
In conclusion, if an alternate specimen is unavailable, we propose that rectal swabs without visible pigment be tested. In the event of a negative result, when clinically indicated, testing of a subsequent stool specimen or a repeat rectal swab could be considered. We suggest that laboratories comment on the visibility of pigment and test performance when reporting results from rectal swabs in order to help clinicians best interpret the results and determine if there is a need for repeat testing. Unfortunately, in our cohort there were few bacterial and parasitic pathogens; thus, additional evidence is needed to guide testing in children where such pathogens are common.
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